AMN Healthcare Services (AMN) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

AMN Healthcare Services

NYSE•Healthcare•Medical Care Facilities

$33.31-1.05(-0.03%)Market open

Market Cap

$1.35B

P/E

12.8x

P/S

0.4x

P/B

1.8x

AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, and allied health professionals, such as skilled nursing facilities, rehabilitation clinics, schools, and pharmacies, as well as physician and advanced practice staffing, and revenue cycle solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists; and solutions for schools, including teletherapy platform, Televate, and qualified school speech-language pathologists, psychologists, nurses, social workers, and other care providers. In addition, it offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. Additionally, the company provides language services, vendor management systems, workforce optimization, and outsourced solutions. The company offers its services under the brands, including AMN Healthcare, Nursefinders, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Texas.

How this company scores

GoodMetricSide Score: 65/100

Strongest: Growth (21/25); weakest: Balance Sheet & Red Flags (12/25).

Profitability16/25

Growth21/25

Balance Sheet & Red Flags12/25

Cash & Earnings Quality16/25

Strengths

Growing revenueRising free cash flowRising earningsProfit converts from growth

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 12.8x5y range 8.9x – 30.5x

Currently near its 14-quarter median.

P/S · 0.4x5y range 0.2x – 1.6x

Currently below its 20-quarter median.

P/B · 1.8x5y range 1.0x – 5.6x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Earnings Quality

Red Flag

FCF consistently trails net income (avg -9.8x) — earnings may be inflated by non-cash items or aggressive accounting.

Price & Volume

Market Cap $1.35B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $3.43B
Q. Revenue: $673.24M
TTM EBITDA: $425.94M
TTM Op. Income: $199.81M
Q. Op. Income: $26.91M
TTM Net Income: $104.92M
Q. Net Income: $21.16M
EPS: $0.54
Shares Out.: $39.02M

$3.43B in TTM revenue grew 24.0% YoY, reaching $673.24M last quarter. TTM EBITDA of $425.94M and TTM operating income of $199.81M show growth is flowing through to the bottom line. TTM net income of $104.92M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 3 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 30.6%
EBITDA Margin: 9.1%
Op. Margin: 4.0%
Net Margin: 3.1%

Op. margin of 4.0% is up 22.8% YoY — cost efficiency is improving. Net margin at 3.1% and gross margin of 30.6% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 121% — a weakening trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 12.8x
P/S Ratio: 0.4x
P/B Ratio: 1.8x

At 12.8x P/E, the stock trades below typical market levels. P/S of 0.4x and P/B of 1.8x provide additional context. P/E sits below typical market levels while revenue is growing. Over the past year, P/E is up 0% — an improving trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $2.36B
Cash: $361.84M
Long-Term Debt: N/A
Book Value: $741.28M
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $-189.93M
TTM Free Cash Flow: $439.13M
FCF Margin: 12.8%
FCF / Net Income: 4.2

TTM FCF of $439.13M on $-189.93M in operating cash flow. The FCF / Net Income ratio of 4.2x means free cash flow covers net income — earnings are backed by cash. Over the past year, free cash flow is up 72% — a weakening trend.